BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:186975@bioscience.fi DTSTART;TZID=Europe/Helsinki:20251002T120000 DTEND;TZID=Europe/Helsinki:20251002T130000 DTSTAMP:20250916T075945Z URL:https://bioscience.fi/events/frontiers-of-science-prof-olli-kallioniem i/ SUMMARY:Frontiers of Science: Prof. Olli Kallioniemi DESCRIPTION:2nd October at 12:00\nOnsite event\nin Presidentti auditorium\, BioCity\nAutumn 2025 program\n\nProf. Olli Kallioniemi\, FIMM\, HiLife\, University of Helsinki\, Finland\nTechnology-\, data- and AI-driven transl ational cancer research\n\nHost: Klaus Elenius (klaele@utu.fi)\n\nCoffee a nd sandwich served at 11:45\, first come first serve!\n\n \;\n\nSix Ph D researchers and early-career postdocs are welcome to have a lunch and di scuss with Prof. Kallioniemi after the seminar. This is a great possibilit y to learn hosting skills in a friendly environment and create connections for future. Everyone is welcome to join\, BioCity Turku will offer the lu nch.\n\nIf you got interested\, please send an email to biocityturku@biosc ience.fi\n\n \;\n\nOlli Kallioniemi is Research Director at the Instit ute for Molecular Medicine Finland (FIMM)\, part of HiLIFE at the Universi ty of Helsinki. He also holds an adjunct professorship in Molecular Precis ion Medicine at Karolinska Institutet.\n\nKallioniemi earned his M.D. and Ph.D.\, along with a specialization in Laboratory Medicine\, at the Univer sity of Tampere\, Finland. He completed a postdoctoral fellowship at UC Sa n Francisco (1990–1992) and subsequently served as a tenure-track group leader at the NHGRI / National Institutes of Health in Bethesda\, MD (1995 –2001). After receiving tenure\, he returned to Finland to direct the Tu rku Medical Biotechnology Unit of VTT/University of Turku. In 2007\, he be came the founding director of FIMM – the Institute for Molecular Medicin e Finland at the University of Helsinki – as part of the Nordic EMBL Par tnership for Molecular Medicine\, a role he held until 2015. From 2015 to 2024\, he served as Director of Science for Life Laboratory (SciLifeLab\, www.scilifelab.se) in Stockholm\, Sweden’s national infrastructure for l ife science\, while also holding a professorship at Karolinska Institutet. \n\nKallioniemi’s research focuses on functional and systems medicine in cancer\, with an emphasis on technology-enabled\, data- and AI-driven pre cision medicine strategies to improve diagnostics and therapy\, particular ly for acute myeloid leukemia and prostate cancer. He was the founding dir ector (2021–2025) of a 12-year\, SEK 3.3 billion (approx. €300 million ) multi-university research program on data-driven life science (DDLS)\, f unded by the Knut and Alice Wallenberg Foundation.\n\nHis current work cen ters on applying AI to the analysis of molecular medicine and human health datasets\, and on developing translational applications of AI. This initi ative is supported by the Brain Gain Research Grant from the Finnish Medic al Foundations (Erkko Foundation\, Sigrid Jusélius Foundation\, and the F innish Medical Society Duodecim). He also co-leads a national initiative b y the Finnish Ministry of Social Affairs and Health and SITRA to plan the future use of health data in Finland.\n\n \;\n\nSelected publications\ n\nImplementing a functional precision medicine tumor board for acute myel oid leukemia. By Malani D\, Ashwini K\, Brück O\, Kontro M P\, Bhagwan Y\ , Hellesøy M\, Kuusanmäki H\, Dufva\, O M J\, Kankainen M J\, Eldfors S\ , Potdar S\, Saarela J\, Turunen L\, Parsons A O\, Västrik I\, Kivinen K\ , Saarela J\, Riikka R\, Lehto M\, Wolf L-M\, Gjertsen B\, Mustjoki S\, Ai ttokallio T A\, Wennerberg K\, Heckman C\, Kallioniemi O*\, Porkka K*. Can cer Discovery. 2022 Feb\;12(2):388-401.\n\nMultiomics and digital monitori ng during lifestyle changes reveal independent dimensions of human biology and health. Marabita F\, James T\, Anu Karhu A\, Virtanen H\, Kettunen K\ , Stenlund H\, Boulund F\, Hellström C\, Neiman M\, Mills R\, Perheentupa T\, Laivuori H\, Helkkula P\, Byrne M\, Jokinen I\, Honko H\, Kallonen A\ , Ermes M\, Similä H\, Lindholm M\, Widen E\, Ripatti S\, Perälä-Heape M\, Engstrand L\, Nilsson P\, Moritz T\, Miettinen T\, Sallinen R\, Kallio niemi O. Cell Systems. 2022 Mar 16\;13(3):241-255.e7.\n\nTrac QT\, Pawitan Y\, Mou T\, Erkers T\, Östling P\, Bohlin A\, Österroos A\, Vesterlund M\, Jafari R\, Siavelis I\, Bäckvall H\, Kiviluoto S\, Orre LM\, Rantalai nen M\, Lehtiö J\, Lehmann S\, Kallioniemi O\, Vu TN. Prediction model fo r drug response of acute myeloid leukemia patients. NPJ Precis Oncol. 2023 Mar 24\;7(1):32.\n\n \;\n\nGeneral information\n\n You can download and save all the autumn 2025 FoS-seminars to your calendar from here: http s://seafile.utu.fi/d/44a70f80ac1e46a9ad0a/\n Registration is not needed\, participation list is circulated in the audience\n If you are a student and later wish to get a certificate of attendance from the Frontier of Sci ence seminars\, print out the seminar diary and after the seminar ask the BioCity coordinator to sign it https://seafile.utu.fi/d/44a70f80ac1e46a9ad 0a/\n Please note that any audio or video recording of the seminars is st rictly forbidden.\n Autumn 2025 image credits to Kari Kaunisto: Sahlberg family collections\, Biodiversity unit\, University of Turku\n\n \; ATTACH;FMTTYPE=image/jpeg:https://bioscience.fi/wp-content/uploads/2025/06 /kallioniemi-500px.jpg CATEGORIES:Turku Bioscience Events END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20250330T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR